Medical Device Innovation Consortium

What Medical Device Innovation Consortium does

Medical Device Innovation Consortium (MDIC) is a 501(c)-style nonprofit public-private partnership founded in 2012 and headquartered in Arlington, Virginia, that operates as a neutral convener for the U.S. medical device regulatory ecosystem. It was established as the first PPP with the sole mission of advancing medical device regulatory science across the total product life cycle, and its members and collaborators include device manufacturers (Boston Scientific, Medtronic, Stryker, Edwards Lifesciences, Novartis, Intuitive), regulators (FDA CDRH), federal research and standards bodies (NIH, NIST, CDC, NCI), payers, providers, and patient groups.

MDIC's deliverables are primarily frameworks, toolkits, and reference standards rather than commercial software. Core programs include NEST (National Evaluation System for health Technology Coordinating Center), which provides Data Quality and Research Methods Frameworks plus the NEST Mark RWD Source Quality Tool for evaluating real-world data sources used in regulatory submissions; the Somatic Reference Samples (SRS) Initiative, which delivers validated cell-line reference materials with clinically relevant cancer variants used in NGS-based diagnostics (now extending to Revvity-NIST's Mimix Geni standards deployed across NCI's ComboMATCH trial); the Early Feasibility Studies (EFS) Playbook and Accelerate EFS Toolkit supporting the EFS program, which has enabled 430+ IDE approvals and 4,000+ study participants since 2014; and additional frameworks covering patient-centered benefit-risk, IVD real-world evidence, and medical device cybersecurity benchmarking. MDIC also operates a Commercial Payer Council and co-hosts the Deloitte R&D Leaders Circle.

MDIC is funded through a combination of annual membership dues from manufacturers, partners, government agencies, patient advocates, and sponsors, supplemented by federal grants (notably FDA grant U01 FD 006292 establishing NESTcc in 2016) and project-specific contributions from foundations (Gordon and Betty Moore Foundation) and corporate partners (Illumina, Quidel). Marketing and distribution run through content (Resource Library, SIGHTLINE bi-monthly newsletter, video library), events (multi-summit format with 600+ attendees in 2025), and direct enterprise membership engagement; pricing is not publicly disclosed. The organization is governed by a multi-stakeholder board representing industry, government, and patient communities, with subsidiaries including NESTcc (wholly owned) and sub-brands such as MDIC Ascend.

Name

Medical Device Innovation Consortium

Legal name

Medical Device Innovation Consortium

Website

https://mdic.org

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Medical Device Innovation Consortium (MDIC) is a nonprofit public-private partnership, founded in 2012, that convenes medical device manufacturers, FDA, NIH, NIST, payers, providers, and patients to advance regulatory science through frameworks, toolkits, and reference standards that accelerate device development, validation, and patient access.

Ownership category

akta.pro rank

Product category

Medical Device Regulatory Science Consortium

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Health Services (8000)

akta.pro primary industry

Healthcare Master Data Management (MDM) & Patient/Provider Identity Data (HLACAIAB)

Keywords

• Medical device regulatory science
• Public-private partnership
• Real-world evidence frameworks
• Clinical trial design
• Medical device quality standards

Headquarters

HQ city

Arlington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Membership Dues: MDIC offers diverse membership types tailored for stakeholders across the medical device ecosystem including manufacturers, partners, government agencies, patient advocates, and sponsors. Members gain access to collaborative networks, working groups, and resources.
2. Foundation and Corporate Funding: MDIC receives funding from foundations and corporate partners for specific initiatives. The SRS Initiative has been funded in part by the Gordon and Betty Moore Foundation, National Philanthropic Trust, Illumina, and Quidel.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

MDIC is a nonprofit public-private partnership that develops regulatory science frameworks, toolkits, reference materials, and best-practice resources to advance medical device innovation. Its offerings include the NEST coordinating center for real-world evidence, the Somatic Reference Samples (SRS) Initiative for NGS-based cancer diagnostics validation, Early Feasibility Studies (EFS) programs, patient engagement frameworks, and medical device cybersecurity assessments.

Product overview

MDIC is a public-private partnership consortium that does not offer a single unified product but rather provides a portfolio of frameworks, tools, initiatives, and collaborative programs focused on advancing medical device regulatory science. The core offerings include the Somatic Reference Samples (SRS) Initiative for NGS-based cancer diagnostics validation; NEST (National Evaluation System for health Technology) coordinating center with its Data Quality Framework and Research Methods Framework v2.0; and the NEST Mark RWD Source Quality Tool. Additional key products include the Early Feasibility Studies (EFS) Playbook and Accelerate EFS Toolkit for regulatory pathway acceleration; the Patient-Centered Benefit-Risk Framework and IVD RWE Framework for clinical and regulatory guidance; the Medical Device Cybersecurity Benchmarking Assessment; and professional community programs like the R&D Leaders Circle and Commercial Payer Council. These offerings are accessed as downloadable resources, collaborative working groups, and coordinating centers rather than traditional software products.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 430 EFS IDEs approved since 2014, with over 70% approved within 30 calendar days
• +4 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core.

• RevvitycoreStrategic or Co-development Partner · 10 November 2025Revvity collaborated with MDIC and NIST to launch new somatic cancer reference standards called Mimix Geni for use in developing and validating NGS-based cancer diagnostics. The standards contain seven oncogenic mutations and are validated for assay sensitivity, specificity, and reproducibility.
• National Cancer Institute (NCI)coreStrategic or Co-development Partner · 22 October 2025MDIC's somatic reference samples are being used to monitor laboratory performance in NCI's ComboMATCH clinical trial, a precision medicine initiative matching cancer patients with targeted therapies. The samples support consistent, reliable genomic testing across 30+ designated laboratories.
• Booz Allen HamiltoncoreImplementation/ SI/ Consulting Partner · 21 November 2023NESTcc selected Booz Allen Hamilton to partner on the Central Data Operations Hub as part of the FDA's active surveillance program for medical devices. The partnership aims to develop and implement an active surveillance system using electronic health data.
• Horizon Discovery (PerkinElmer)coreStrategic or Co-development Partner · 19 October 2022MDIC partnered with Horizon Discovery to develop and manufacture somatic reference samples (SRSs) to simplify and support validation of NGS-based cancer diagnostics. Horizon uses CRISPR technology to engineer and manufacture SRSs containing cancer-associated gene variants. The fully characterized SRSs are commercially available through Horizon Discovery.
• U.S. Food and Drug Administration (FDA)coreStrategic or Co-development Partner · 1 January 2018FDA is a key collaborator in MDIC initiatives including the SRS Initiative, NEST, and various working groups. FDA participates in developing guidance, providing regulatory insights, and supporting evidence generation frameworks.
• National Institute of Standards and Technology (NIST)coreStrategic or Co-development PartnerNIST collaborates on the Somatic Reference Samples Initiative, providing expertise in reference sample validation and dataset generation. NIST's Biomarker and Genomic Sciences Group co-leads validation efforts using the GIAB cell lines.
• National Institutes of Health (NIH)coreStrategic or Co-development PartnerNIH participates in MDIC's SRS Initiative and collaborative efforts to advance regulatory science for medical devices and diagnostics.
• Centers for Disease Control and Prevention (CDC)coreStrategic or Co-development PartnerCDC collaborates as part of the SRS Initiative working group addressing reference material gaps for NGS-based diagnostic tests.
• DeloittecoreStrategic or Co-development PartnerMDIC and Deloitte co-host the R&D Leaders Circle, a forum for MedTech professionals to share insights, benchmark practices, and explore solutions. Deloitte also conducts the MedTech Product Development Benchmarking Program.
• Frederick National Laboratory for Cancer ResearchcoreStrategic or Co-development PartnerThe Molecular Characterization Laboratory at Frederick National Laboratory supports ComboMATCH by distributing MDIC's reference samples across participating laboratories, collecting variant results, and performing concordance analysis.
• Performance Review Institute (PRI)coreStrategic or Co-development PartnerMDIC coordinated the pilot study evaluating the MedAccred Sterilization Audit Program administered by PRI. MedAccred provides expert-led audits to reduce redundant evaluations and improve quality assurance in medical device manufacturing.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Critical Path Institute (C-Path): Nonprofit public-private partnership that similarly convenes FDA, industry, and academia to advance regulatory science—focused on drug development rather than devices. Closest structural analog to MDIC's PPP model.
• Association for the Advancement of Medical Instrumentation (AAMI): Standards-developing organization for medical devices; produces consensus standards used by FDA. Directly comparable on the medical device quality/standards side of MDIC's portfolio.
• ECRI Institute: Independent nonprofit improving patient safety, evidence-based medicine, and medical device evaluation; shares MDIC's mission of independent evidence generation and patient safety for medical technology.

Broad incumbents

• AdvaMed: Primary US medical device industry trade association; serves MDIC's same OEM members (Boston Scientific, Medtronic, Stryker etc.) but with policy/advocacy focus rather than direct regulatory science delivery.
• NSF (National Sanitation Foundation): Independent standards/auditing body that issues certifications for medical device quality systems; overlaps with MDIC's quality and manufacturing programs (e.g., MedAccred).
• UL Standards & Engagement: Safety science and standards organization with medical device cybersecurity and standards practice; comparable on device safety/standards, broader portfolio than MDIC.

Emerging players

• NIST (National Institute of Standards and Technology): Federal partner inside MDIC's SRS Initiative; also produces reference materials and genomic standards (GIAB) that overlap with MDIC's SRS work. Comparable on reference materials and validation frameworks.
• MDEpiNet (Medical Device Epidemiology Network): FDA-funded multi-stakeholder initiative coordinating medical device epidemiology and real-world evidence. Closely overlaps with MDIC's NESTcc mission and shares several federal partners.

Regional players

• MedTech Europe: European medtech industry association covering EU regulatory/scientific topics analogous to MDIC's US role; useful peer for MDIC's lack of European footprint.

Others

• PCORI (Patient-Centered Outcomes Research Institute): US nonprofit research funder backing patient-centered comparative effectiveness studies; shares MDIC's patient-preference and patient-engagement priorities.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@mdic.org
• LinkedInlinkedin.com/company/medical-device-innovation-consortium
• Xx.com/MDIConline

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Device Innovation Consortium